Haemorrhagic Colitis Caused by Dasatinib

被引:19
作者
Patodi, Nishant [1 ]
Sagar, Nidhi [1 ]
Rudzki, Zbigniew [2 ]
Langman, Gerald [2 ]
Sharma, Naveen [1 ]
机构
[1] Heart England Fdn Trust, Dept Gastroenterol, Birmingham B9 5SS, England
[2] Heart England Fdn Trust, Dept Histopathol, Birmingham B9 5SS, England
关键词
D O I
10.1155/2012/417106
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gastrointestinal bleeding appears to be a common adverse event associated with dasatinib therapy. Here we present a case of a 59-year-old man with chronic myeloid leukaemia (CML) developing the rarest complication of haemorrhagic colitis with dasatinib therapy which resolved rapidly after treatment withdrawal.
引用
收藏
页数:4
相关论文
共 16 条
[1]   Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet [J].
Baccarani, Michele ;
Cortes, Jorge ;
Pane, Fabrizio ;
Niederwieser, Dietger ;
Saglio, Giuseppe ;
Apperley, Jane ;
Cervantes, Francisco ;
Deininger, Michael ;
Gratwohl, Alois ;
Guilhot, Francois ;
Hochhaus, Andreas ;
Horowitz, Mary ;
Hughes, Timothy ;
Kantarjian, Hagop ;
Larson, Richard ;
Radich, Jerald ;
Simonsson, Bengt ;
Silver, Richard T. ;
Goldman, John ;
Hehlmann, Rudiger .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) :6041-6051
[2]   Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib) [J].
Chen, ZM ;
Lee, FY ;
Bhalla, KN ;
Wu, J .
MOLECULAR PHARMACOLOGY, 2006, 69 (05) :1527-1533
[3]   Metabolism and disposition of dasatinib after oral administration to humans [J].
Christopher, Lisa J. ;
Cui, Donghui ;
Wu, Chiyuan ;
Luo, Roger ;
Manning, James A. ;
Bonacorsi, Samuel J. ;
Lago, Michael ;
Allentoff, Alban ;
Lee, Francis Y. F. ;
McCann, Betty ;
Galbraith, Susan ;
Reitberg, Donald P. ;
He, Kan ;
Barros, Anthony, Jr. ;
Blackwood-Chirchir, Anne ;
Humphreys, W. Griffith ;
Iyer, Ramaswamy A. .
DRUG METABOLISM AND DISPOSITION, 2008, 36 (07) :1357-1364
[4]   A Case of Acute Colitis with Severe Rectal Bleeding in a Patient with Chronic Myeloid Leukemia after Dasatinib Use [J].
Erkut, Murat ;
Erkut, Nergiz ;
Ersoz, Safak ;
Arslan, Mehmet ;
Sonmez, Mehmet .
ACTA HAEMATOLOGICA, 2010, 123 (04) :205-206
[5]   The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo [J].
Gratacap, Marie-Pierre ;
Martin, Valerie ;
Valera, Marie-Cecile ;
Allart, Sophie ;
Garcia, Cedric ;
Sie, Pierre ;
Recher, Christian ;
Payrastre, Bernard .
BLOOD, 2009, 114 (09) :1884-1892
[6]   Pericyte loss and microaneurysm formation in PDGF-B-deficient mice [J].
Lindahl, P ;
Johansson, BR ;
Leveen, P ;
Betsholtz, C .
SCIENCE, 1997, 277 (5323) :242-245
[7]   Discovery of N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays [J].
Lombardo, LJ ;
Lee, FY ;
Chen, P ;
Norris, D ;
Barrish, JC ;
Behnia, K ;
Castaneda, S ;
Cornelius, LAM ;
Das, J ;
Doweyko, AM ;
Fairchild, C ;
Hunt, JT ;
Inigo, I ;
Johnston, K ;
Kamath, A ;
Kan, D ;
Klei, H ;
Marathe, P ;
Pang, SH ;
Peterson, R ;
Pitt, S ;
Schieven, GL ;
Schmidt, RJ ;
Tokarski, J ;
Wen, ML ;
Wityak, J ;
Borzilleri, RM .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (27) :6658-6661
[8]  
Mauro M., 2008, AM SOC CLIN ONCOLOGY, V26
[9]   Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy [J].
Mustjoki, S. ;
Ekblom, M. ;
Arstila, T. P. ;
Dybedal, I. ;
Epling-Burnette, P. K. ;
Guilhot, F. ;
Hjorth-Hansen, H. ;
Hoglund, M. ;
Kovanen, P. ;
Laurinolli, T. ;
Liesveld, J. ;
Paquette, R. ;
Pinilla-Ibarz, J. ;
Rauhala, A. ;
Shah, N. ;
Simonsson, B. ;
Sinisalo, M. ;
Steegmann, J. L. ;
Stenke, L. ;
Porkka, K. .
LEUKEMIA, 2009, 23 (08) :1398-1405
[10]   Hemorrhagic colonic ulcers caused by dasatinib for chronic myelogenous leukemia [J].
Ono, Yukako ;
Mori, Takehiko ;
Kato, Jun ;
Yamane, Akiko ;
Yajima, Tomoharu ;
Iwao, Yasushi ;
Hibi, Toshifumi ;
Okamoto, Shinichiro .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (03) :556-558